Harmless glucose-modified ruthenium complexes suppressing cell migration of highly invasive cancer cell lines

Glucose-substituted ruthenium complexes [(η⁶-benzyl-glucose)RuCp*]⁺Cl⁻, where Cp* = η⁵-C₅Me₅; benzyl-glucose = peracetylated benzyl β-d -glucopyranoside ( 1 ), benzyl β-d -glucopyranoside ( 2 ), have been prepared and used as efficient antimigration and anti-invasive agents against metastatic breast cancer cells (MDA-MB-231) and cisplatin-resistant ovarian cancer cells (SK-OV-3). In addition, these complexes were found to be essentially non-toxic against non-cancerous human kidney cells (HEK293).     

Tricarbonylrhenium(I) complexes with the N,6-dimethylpyridine-2-carbothioamide ligand: combined experimental and calculation studies

Abstract

A new series of tricarbonyl complexes of rhenium(I) in the “2 + 1” system with the bidentate ligand N,6-dimethylpyridine-2-carbothioamide ((CH₃)NC₅H₄-CS-NH-CH₃, MeLH(Me)_NS) and a monodentate ligand (halides Cl, Br, or I, and the pseudohalide NCS anion) was synthesized. The use of mixed ligands led to the formation of neutral tricarbonylrhenium(I) complexes [Re(CO)₃(MeLH(Me)_NS)X] (X = Cl, Br, I, NCS) (1–4). Single-crystal X-ray diffraction was used to determine the crystal structures of all four compounds and those results were compared with molecular structures obtained from DFT calculations using the PBE0/def2-TZVPD approach. The complexes were also characterized by spectroscopic (FT-IR, NMR, and UV–vis) and analytical (HPLC, TGA, EA, ESI-MS) techniques. IR and UV–vis spectra were also calculated by DFT and TD-DFT methods. The cytotoxicity of these complexes was estimated using human ovarian cancer cell lines (A2780 and A2780cis), cervical cancer cells (HeLa), and non-cancerous human embryonic kidney cells (Hek-293). The toxicity of most complexes was moderate or low toward cancer cell lines (IC₅₀ = 46–231 μM) and similar against non-cancerous cells (IC₅₀ = 41-121 μM). Only the complex with chlorido ligand remarkably inhibited growth of ovarian cancer cells (IC₅₀ = 3 and 12 μM for A2780 and A2780cis, respectively). The cytotoxicity of 1 was higher than that of cisplatin.     

A Bis-Chelating / Ligand for the Synthesis of Heterobimetallic Platinum(II)/Rhenium(I) Complexes: Tools for the Optimization of a New Class of Platinum(II) Anticancer Agents

The two independent and coordination sites of a newly synthesized bis[2-(hydroxyphenyl)-1,2,4-triazole] platform have been exploited to prepare four monometallic neutral ()Pt^II complexes carrying DMSO, pyridine, triphenylphosphine, or N-heterocyclic carbene as the fourth ligand. Then, the second coordination site was used to introduce an IR-active rhenium tricarbonyl entity, affording the four corresponding heterobimetallic neutral Pt^II/Re^I complexes, as well as a cationic Pt^II/Re^I derivative. X-ray crystallographic studies showed that distortion of the organic platform occurred to accommodate the coordination geometry of both metal centers. No ligand exchange or transchelation occurred upon incubation of the Pt^II complexes in aqueous environment or in the presence of Fe^III, respectively. The antiproliferative activity of the ligand and complexes was first screened on the triple-negative breast cancer cell line MDA-MB-231. Then, the IC₅₀ values of the most active candidates were determined on a wider panel of human cancer cells (MDA-MB-231, MCF-7, and A2780), as well as on a nontumorigenic cell line (MCF-10A). Low micromolar activities were reached for the complexes carrying a DMSO ligand, making them the first examples of highly active, but hydrolytically stable, Pt^II complexes. Finally, the characteristic mid-IR signature of the {Re(CO)₃} fragment in the Pt/Re heterobimetallic complexes was used to quantify their uptake in breast cancer cells.     

Cover Image

The novel heteronuclear complexes [{cis-PtCl (NH₃)(μ-pyrazine)ZnCl (terpy)}](ClO₄)₂ (Pt-L1-Zn) and [{cis-PtCl (NH₃)(μ-4,4′-bipyridyl)ZnCl (terpy)}](ClO₄)₂ (Pt-L2-Zn) (where terpy = 2,2′:6′,2′′-terpyridine, L1 = pyrazine, L2 = 4,4′-bipyridyl) were synthesized and characterized. The pK_a values were determined, and based on them it was established that the π-acceptor ability of the pyrazine bridging ligand is more affective on lower pK_a values. The kinetic measurements of the substitution reactions with biologically relevant ligands, such as guanosine-5′-monophosphate (5′-GMP), inosine-5′-monophosphate (5′-IMP) and glutathione (GSH), were studied at pH 7.4. The reactions were followed under pseudo-first-order conditions by UV–Vis spectrophotometry. The order of reactivity of the investigated biomolecules for the first reaction is 5′-GMP > 5′-IMP > GSH, while for the second is 5′-IMP > GSH. Pt-L1-Zn complex is more reactive than Pt-L2-Zn. The cytotoxic activity of heteronuclear Pt-L1-Zn and Pt-L2-Zn complexes was determined on human colorectal cancer cell line (HCT-116) and human breast cancer cell line (MDA-MB-231). Both complexes significantly reduced cell viability on tested cell lines and exerted significant cytotoxic effects, with better effect on HCT-116 cells than cisplatin, especially after 72 hr (IC₅₀ < 0.52 μM). The Pt-L2-Zn complex showed higher activity against human breast cancer cells (MDA-MB-231) than cisplatin after 72 hr. The higher reactivity toward DNA constituent and significant cytotoxic activity may be attributed to the different geometry, Lewis acidity of different metal centers, as well as, to choice of bridging ligands.     

Synthesis,characterization, antibacterial,and cytotoxic activities of organotin(IV) complexes derived from N(4)-cyclohexylthiosemicarbazone: X-ray crystal structure of [Ph2SnCl(L)]

Reaction of organotin(IV) chloride(s) with 2-benzoylpyridine-N(4)-cyclohexylthiosemicarbazone, [HL] (1) yielded [MeSnCl₂(L)] (2), [BuSnCl₂(L)] (3), [Me₂SnCl(L)] (4), and [Ph₂SnCl(L)] (5). The ligand (1) and its organotin(IV) complexes have been characterized by CHN analyses, molar conductivity, UV-Vis, FT-IR, ¹H, ¹³C, and ¹¹⁹Sn NMR spectral studies. The molecular structure of 5 was also determined by X-ray diffraction. There are two independent molecules in the asymmetric unit and the central tin(IV) atom is six-coordinate in distorted octahedral geometry. The ligand (1) and complexes were screened for their in vitro antibacterial activities. The cytotoxic activities of 1–5 were tested against A2780 and A2780/Cp8 cancer cell lines. The compounds have better antibacterial activities than the free ligand; 2–5 are more potent cytotoxic agents than 1, while the diphenyltin(IV) 5 is more active with IC₅₀ values of 0.05 and 0.54?µmol?L^?1 against A2780 and A2780/Cp8 cell lines, respectively.     

Zur Reaktivität von Titanocenkomplexen [Ti(Cp′)2(η2‐Me3SiC≡CSiMe3)] (Cp′ = Cp,Cp*) gegenüber Benzoldicarbonsäuren

On the Reactivity of Titanocene Complexes [Ti(Cp′)₂(η²‐Me₃SiC≡CSiMe₃)] (Cp′ = Cp, Cp*) towards Benzenedicarboxylic Acids Titanocene complexes [Ti(Cp′)₂(BTMSA)] ( 1a , Cp′ = Cp = η⁵‐C₅H₅; 1b , Cp′ = Cp* = η⁵‐C₅Me₅; BTMSA = Me₃SiC≡CSiMe₃) were found to react with iodine and methyl iodide yielding [Ti(Cp′)₂(μ‐I)₂] ( 2a / b ; a refers to Cp′ = Cp and b to Cp′ = Cp*), [Ti(Cp′)₂I₂] ( 3a / b ) and [Ti(Cp′)₂(Me)I] ( 4a / b ), respectively. In contrast to 2a , complex 2b proved to be highly moisture sensitive yielding with cleavage of HCp* [{Ti(Cp*)I}₂(μ‐O)] ( 7 ). The corresponding reactions of 1a / b with p‐cresol and thiophenol resulted in the formation of [Ti(Cp′)₂{O(p‐Tol)}₂] ( 5a / b ) and [Ti(Cp′)₂(SPh)₂] ( 6a / b ), respectively. Reactions of 1a and 1b with 1,n‐benzenedicarboxylic acids (n = 2–4) resulted in the formation of dinuclear titanium(III) complexes of the type [{Ti(Cp′)₂}₂{μ‐1,n‐(O₂C)₂C₆H₄}] (n = 2, 8a / b ; n = 3, 9a / b ; n = 4, 10a / b ). All complexes were fully characterized analytically and spectroscopically. Furthermore, complexes 7 , 8b , 9a ·THF, 10a / b were also be characterized by single‐crystal X‐ray diffraction analyses.     

Versatile reactivity of half-sandwich Ir and Rh complexes toward carboranylamidinates and their derivatives: synthesis, structure, and catalytic activity for norbornene polymerization

Synthesis, structure, and reactivity of carboranylamidinate‐based half‐sandwich iridium and rhodium complexes are reported for the first time. Treatment of dimeric metal complexes [{Cp*M(μ‐Cl)Cl}₂] (M=Ir, Rh; Cp*=η⁵‐C₅Me₅) with a solution of one equivalent of nBuLi and a carboranylamidine produces 18‐electron complexes [Cp*IrCl(Cab^N‐DIC)] ( 1 a ; Cab^N‐DIC=[iPrN?C(closo‐1,2‐C₂B₁₀H₁₀)(NHiPr)]), [Cp*RhCl(Cab^N‐DIC)] ( 1 b ), and [Cp*RhCl(Cab^N‐DCC)] ( 1 c ; Cab^N‐DCC=[CyN?C(closo‐1,2‐C₂B₁₀H₁₀)(NHCy)]). A series of 16‐electron half‐sandwich Ir and Rh complexes [Cp*Ir(Cab^N′‐DIC)] ( 2 a ; Cab^N′‐DIC=[iPrN?C(closo‐1,2‐C₂B₁₀H₁₀)(NiPr)]), [Cp*Ir(Cab^N′‐DCC)] ( 2 b , Cab^N′‐DCC=[CyN?C(closo‐1,2‐C₂B₁₀H₁₀)(NCy)]), and [Cp*Rh(Cab^N′‐DIC)] ( 2 c ) is also obtained when an excess of nBuLi is used. The unexpected products [Cp*M(Cab^N,S‐DIC)], [Cp*M(Cab^N,S‐DCC)] (M=Ir 3 a , 3 b ; Rh 3 c , 3 d ), formed through BH activation, are obtained by reaction of [{Cp*MCl₂}₂] with carboranylamidinate sulfides [RN?C(closo‐1,2‐C₂B₁₀H₁₀)(NHR)]S^? (R=iPr, Cy), which can be prepared by inserting sulfur into the C? Li bond of lithium carboranylamidinates. Iridium complex 1 a shows catalytic activities of up to 2.69×10⁶ g_PNB ${{\rm{mol}}_{{\rm{Ir}}}^{ - {\rm{1}}} }Synthesis, structure, and reactivity of carboranylamidinate-based half-sandwich iridium and rhodium complexes are reported for the first time. Treatment of dimeric metal complexes [{Cp*M(μ-Cl)Cl}(2)] (M = Ir, Rh; Cp* = η(5)-C(5)Me(5)) with a solution of one equivalent of nBuLi and a carboranylamidine produces 18-electron complexes [Cp*IrCl(Cab(N)-DIC)] (1?a; Cab(N)-DIC = [iPrN=C(closo-1,2-C(2)B(10)H(10))(NHiPr)]), [Cp*RhCl(Cab(N)-DIC)] (1?b), and [Cp*RhCl(Cab(N)-DCC)] (1?c; Cab(N)-DCC = [CyN=C(closo-1,2-C(2)B(10)H(10))(NHCy)]). A series of 16-electron half-sandwich Ir and Rh complexes [Cp*Ir(Cab(N')-DIC)] (2?a; Cab(N')-DIC = [iPrN=C(closo-1,2-C(2)B(10)H(10))(NiPr)]), [Cp*Ir(Cab(N')-DCC)] (2?b, Cab(N')-DCC = [CyN=C(closo-1,2-C(2)B(10)H(10)(NCy)]), and [Cp*Rh(Cab(N')-DIC)] (2?c) is also obtained when an excess of nBuLi is used. The unexpected products [Cp*M(Cab(N,S)-DIC)], [Cp*M(Cab(N,S)-DCC)] (M = Ir 3?a, 3?b; Rh 3?c, 3?d), formed through BH activation, are obtained by reaction of [{Cp*MCl(2)}(2)] with carboranylamidinate sulfides [RN=C(closo-1,2-C(2)B(10)H(10))(NHR)]S(-) (R = iPr, Cy), which can be prepared by inserting sulfur into the C-Li bond of lithium carboranylamidinates. Iridium complex 1?a shows catalytic activities of up to 2.69×10(6) g(PNB) mol(Ir)(-1) h(-1) for the polymerization of norbornene in the presence of methylaluminoxane (MAO) as cocatalyst. Catalytic activities and the molecular weight of polynorbornene (PNB) were investigated under various reaction conditions. All complexes were fully characterized by elemental analysis and IR and NMR spectroscopy; the structures of 1?a-c, 2?a, b; and 3?a, b, d were further confirmed by single crystal X-ray diffraction.     

Antiproliferative activities of 2-hydroxyethyl substituted benzimidazolium salts and their palladium complexes against human cancerous cell lines

Abstract

Benzimidazolium salts (1a and 1b) and respective palladium complexes (2a and 2b) were prepared and characterized with ¹H and ¹³C NMR, IR, elemental analysis as well as HRMS (for 2a). All target compounds were screened as potential anticancer agents against human cell lines for assessing their cytotoxicity. Heterocyclic organic compounds (1a and 1b) showed more cytotoxic activity than their complexes (2a and 2b) in the tested two cell lines. Particularly, a benzimidazolium salt including a 4-methylbenzyl group had a high cytotoxic potency towards MDA-MB-231 and DLD-1 cell lines with IC₅₀ values comparable to a well-known anticancer drug cisplatin, which is generally used in clinical studies. Furthermore, a compound namely 1-(2-hydroxyethyl)-3-(2,3,4,5,6-pentamethylbenzyl)-1H-benzo[d]imidazol-3-ium bromide was found to be more cytotoxic activity in MDA-MB-231 cell line compared to cisplatin with following IC₅₀ value of 7.59?±?0.68?μM.     

Syntheses,Structures, and Electronic Properties of Mono- and Bimetallic Thiolato Complexes Containing Unusual Coordination Modes of Thiolato Ligands

Synthesis, bonding and chemistry of mono- and bimetallic complexes supported by chelating thiolato ligands have been established. Treatment of [Cp*VCl₂]₃ ( 1 ) with [LiBH₄ ⋅ THF] followed by the addition of ethane-1,2-dithiol led to the formation of an EPR active bimetallic vanadium thiolato complex [(Cp*V){μ-(SCH₂CH₂S)-κ²S,S′)₂{V(SCH₂CH₂S-SH)}] ( 2 ). In complex 2 , two ethane-1,2-dithiolato ligands are symmetrically coordinated to two vanadium atoms through μ-S atoms. Interestingly, when similar reactions were carried out with heavier group 5 metal precursors, such as [Cp*NbCl₄] ( 3 a ), it afforded monometallic thiolato complex [Cp*Nb(SCH₂CH₂S)(SCH₂CH₂S−CH₂S)] ( 4 a ). On the other hand, the Ta-analogue [Cp*TaCl₄] ( 3 b ) yielded thiolato species [Cp*Ta(SCH₂CH₂S)(SCH₂CH₂S−CH₂S)] ( 4 b ) and [Cp*Ta(SCH₂CH₂S) (SCH₂CH₂S−S)] ( 5 ). In complexes 4 a and 4 b , one ethane-1,2-dithiolato and one trithiolato ligand are coordinated to Nb and Ta centers, respectively. Whereas, in complex 5 , one ethane-1,2-dithiolato and one 2-disulfanylethanethiolato is coordinated to the Ta center. Moreover, the photolytic reaction of 5 with [Mo(CO)₅ ⋅ THF] yielded heterobimetallic thiolato complex [(Cp*Ta){μ-(SCH₂CH₂S)-κ²S,S′}{μ-(SCH₂CH₂S−CH₂(CH₃)S)κ²S′′ : κ¹S-′′′′ : κ¹S′′′′′}{Mo(CO)₃}] ( 6 ). All the complexes have been characterized by multinuclear NMR spectroscopy and single crystal X-ray diffraction studies. Further, computational analyses were performed to provide an insight into the bonding of these complexes.     

Chemistry of Diruthenium and Dirhodium Analogues of Pentaborane(9): Synthesis and Characterization of Metal N,S‐Heterocyclic Carbene and B‐Agostic Complexes

Building upon our earlier results on the synthesis of electron‐precise transition‐metal–boron complexes, we continue to investigate the reactivity of pentaborane(9) and tetraborane(10) analogues of ruthenium and rhodium towards thiazolyl and oxazolyl ligands. Thus, mild thermolysis of nido‐[(Cp*RuH)₂B₃H₇] ( 1 ) with 2‐mercaptobenzothiazole (2‐mbtz) and 2‐mercaptobenzoxazole (2‐mboz) led to the isolation of Cp*‐based (Cp*=η⁵‐C₅Me₅) borate complexes 5 a , b [Cp*RuBH₃L] ( 5 a : L=C₇H₄NS₂; 5 b : L=C₇H₄NOS)) and agostic complexes 7 a , b [Cp*RuBH₂(L)₂], ( 7 a : L=C₇H₄NS₂; 7 b : L=C₇H₄NOS). In a similar fashion, a rhodium analogue of pentaborane(9), nido‐[(Cp*Rh)₂B₃H₇] ( 2 ) yielded rhodaboratrane [Cp*RhBH(L)₂], 10 (L=C₇H₄NS₂). Interestingly, when the reaction was performed with an excess of 2‐mbtz, it led to the formation of the first structurally characterized N,S‐heterocyclic rhodium‐carbene complex [(Cp*Rh)(L₂)(1‐benzothiazol‐2‐ylidene)] ( 11 ) (L=C₇H₄NS₂). Furthermore, to evaluate the scope of this new route, we extended this chemistry towards the diruthenium analogue of tetraborane(10), arachno‐[(Cp*RuCO)₂B₂H₆] ( 3 ), in which the metal center possesses different ancillary ligands.     

Neue Rheniumkomplexe mit Trichalkogenido- und Tetrachalkogenido-Chelatliganden

New Rhenium Complexes Containing Trichalcogenido and Tetrachalcogenido Chelate Ligands The reactions of Cp*ReCl₄ with polychalcogenide salts such as Na₂S₄ or (NEt₄)₂Se₆ lead initially to the violet trichalcogenido chelate complexes Cp*ReCl₂(E₃) (E = S ( 3a ), Se ( 3b )) which, due to their functional chloro ligands, can be used as intermediates for further reactions. Upon hydrolysis in moist solvents or aminolysis with tert. butylamine 3a, b are converted into the tetrachalcogenido chelate complexes Cp*Re(O)(E₄) (E = S ( 4a ), Se ( 4b )) and Cp*Re(N^tBu)(E₄) (E = S ( 5a ), Se ( 5b )), respectively. X-Ray structure analyses were carried out for the three mononuclear cyclo-oligoselenido compounds 3b–5b . It appears that the size of the Se^2?_n chelate ring (n = 3 or 4) essentially depends on steric factors within the coordination sphere of rhenium.     

Ring Expansions of Nonpolar Polyphosphorus Rings

The reaction of the phosphinidene complex [Cp*P{W(CO)₅}₂] ( 1 a ) (Cp*=C₅Me₅) with the anionic cyclo-P_n ligand complex [(η³-P₃)Nb(ODipp)₃]⁻ ( 2 , Dipp=2,6-diisopropylphenyl) resulted in the formation of [{W(CO)₅}₂{μ₃,η^3:1:1-P₄Cp*}Nb(ODipp)₃]⁻ ( 3 ), which represents an unprecedented example of a ring expansion of a polyphosphorus-ligand complex initiated by a phosphinidene complex. Furthermore, the reaction of the pnictinidene complexes [Cp*E{W(CO)₅}₂] (E=P: 1 a , As: 1 b ) with the neutral complex [Cp′′′Co(η⁴-P₄)] (Cp′′′=1,2,4-tBu₃C₅H₂) led to a cyclo-P₄E ring (E=P, As) through the insertion of the pentel atom into the cyclo-P₄ ligand. Starting from 1 a , the two isomers [Cp′′′Co(μ₃,η^4:1:1-P₅Cp*){W(CO)₅}₂] ( 5 a , b ), and from 1 b , the three isomers [Cp′′′Co(μ₃,η^4:1:1-AsP₄Cp*){W(CO)₅}₂] ( 6 a – c ) with unprecedented cyclo-P₄E ligands (E=P, As) were isolated. The complexes 6 a – c represent unique examples of ring expansions which lead to new mixed five-membered cyclo-P₄As ligands. The possible reaction pathways for the formation of 5 a , b and 6 a – c were investigated by a combination of temperature-dependent ³¹P{¹H} NMR studies and DFT calculations.     

Four‐Membered Heterometallacyclic d0 and d1 Complexes of Group 4 Metallocenes with Amidato Ligands

A study of the coordination chemistry of different amidato ligands [(R)N?C(Ph)O] (R=Ph, 2,6‐diisopropylphenyl (Dipp)) at Group 4 metallocenes is presented. The heterometallacyclic complexes [Cp₂M(Cl){κ²‐N,O‐(R)N?C(Ph)O}] M=Zr, R=Dipp ( 1 a ), Ph ( 1 b ); M=Hf, R=Ph ( 2 )) were synthesized by reaction of [Cp₂MCl₂] with the corresponding deprotonated amides. Complex 1 a was also prepared by direct deprotonation of the amide with Schwartz reagent [Cp₂Zr(H)Cl]. Salt metathesis reaction of [Cp₂Zr(H)Cl] with deprotonated amide [(Dipp)N?C(Ph)O] gave the zirconocene hydrido complex [Cp₂M(H){κ²‐N,O‐(Dipp)N?C(Ph)O}] ( 3 ). Reaction of 1 a with Mg did not result in the desired Zr(III) complex but in formation of Mg complex [(py)₃Mg(Cl) {κ²‐N,O‐(Dipp)N?C(Ph)O}] ( 4 ; py=pyridine). The paramagnetic complexes [Cp′₂Ti{κ²‐N,O‐(R)N?C(Ph)O}] (Cp′=Cp, R=Ph ( 7 a ); Cp′=Cp, R=Dipp ( 7 b ); Cp′=Cp*, R=Ph ( 8 )) were prepared by the reaction of the known titanocene alkyne complexes [Cp₂′Ti(η²‐Me₃SiC₂SiMe₃)] (Cp′=Cp ( 5 ), Cp′=Cp* ( 6 )) with the corresponding amides. Complexes 1 a , 2 , 3 , 4 , 7 a , 7 b , and 8 were characterized by X‐ray crystallography. The structure and bonding of complexes 7 a and 8 were also characterized by EPR spectroscopy.     

Synthesis,characterization, and cytotoxic activity studies of new N4O complexes derived from 2-({3-[2-morpholinoethylamino]-N3-([pyridine-2-yl]methyl) propylimino} methyl)phenol

A new unsymmetrical five-coordinate Schiff base ligand (HL) with an N₄O donor set ( 2 ) has been prepared by condensation of N1-(2-morpholinoethyl)-N1-([pyridine-2-yl]methyl)propane-1,3-diamine with 2-hydroxy-benzaldehyde. Metal complexes [ML]ⁿ⁺ (M = Zn²⁺, Cd²⁺, Mn²⁺, Cu²⁺, Ni²⁺, Ag⁺, Fe³⁺, and Co²⁺ ( 3–10 ) were synthesized by the reaction of the ligand and metal salts in ethanol. The resulting products were characterized by elemental analyses, infrared, ¹H and ¹³C nuclear magnetic resonance spectra (in the case of Cd and Zn complexes), UV–Vis, electrospray ionization-mass spectrometric, and conductivity measurements. The structure of the complexes [ZnL](ClO₄) ( 3 ), [CdL](ClO₄) ( 4 ), and [CuL](ClO₄) ( 7 ) has been determined by single-crystal X-ray diffraction analysis. The metal complexes were determined to have a distorted trigonal bipyramidal (Zn and Cd) or a distorted square pyramidal (Cu) geometry. The cytotoxic potential of each compound (1–10) against MCF-7 and MDA-MB-231 (breast cancer cells), PC-3 (prostate cancer cells), and WI-38 human normal lung fibroblast cells was evaluated using the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) assay. Compounds 1, 2, and 10 did not display any activity toward any cell line tested. None of the compounds except compound 8 was cytotoxic toward PC-3. Compounds 4 and 8 showed the highest cytotoxic activity against the MCF-7 and MDA-MB-231 cell lines. Because compounds 3, 6, and 9 have similar half-maximal inhibitory concentration values against cancer cells and normal cells, these compounds displayed poor selectivity between cancer and normal cells. More importantly, it was observed that compound 5 acts differently toward different types of cell lines. For example, it displays lower cytotoxicity against the WI-38 normal cell line than it does against the MDA-MB-231 cell line.     

Synthesis and Antitumor Evaluation of Novel Hybrids of Phenylsulfonylfuroxan and Estradiol Derivatives

Fifteen novel furoxan-based nitric oxide (NO) releasing hybrids of estradiol derivatives were synthesized and evaluated in vitro anti-proliferative activity in MDA-MB-231, A2780, Hela and HUVEC cell lines. Most of them displayed potent anti-proliferative effects. Among the compounds, 4-bromo-3-((phenylsulfonyl)-1,2,5-oxadiazole 2-oxide)-oxy-propoxy-estradiol ( 11 b ) exhibited the best activity with IC₅₀ values of 3.58–0.0008 μM. Preliminary pharmacological studies showed that 11 b induced apoptosis and hardly affected the cell cycle of MDA-MB-231 cell line. NO-releasing capacity and inhibition of ERK/MAPK pathway signaling might explain the potent antineoplastic activity of these compounds. The preliminary structure-activity relationship (SAR) showed that steroidal scaffolds with a linker in 3-position were favorable moieties to evidently increase the bioactivities of these hybrids. Overall, these results implied that 11 b merited to be further investigated as a promising anti-cancer candidate.     

Zur Reaktivität des Ferriophosphaalkens (Z)‐[Cp*(CO)2FeP=C(tBu)NMe2] gegenüber Propiolsäureestern HC≡C‐CO2R (R=Me,Et) und Acetylendicarbonsäureestern RO2C‐C≡C‐CO2R (R=Me,Et, tBu)

On the Reactivity of the Ferriophosphaalkene (Z)‐[Cp*(CO)₂Fe‐P=C(tBu)NMe₂] towards Propiolates HC≡C‐CO₂R (R=Me, Et) and Acetylene Dicarboxylates RO ₂C‐C≡C‐CO₂R (R=Me, Et, tBu) The reaction of equimolar amounts of (Z)‐[Cp*(CO)₂Fe‐P=C(tBu)NMe₂] 3 and methyl‐ and ethyl‐propiolate ( 2a, b ) or of 3 and dialkyl acetylene dicarboxylates 1a (R=Me), 1b (Et), 1c (tBu) afforded the five‐membered metallaheterocycles [Cp*(CO) =C(tBu)NMe₂] ( 4a, b ) and [Cp*(CO) =C(tBu)NMe₂] ( 5a—c ). The molecular structures of 4b and 5a were elucidated by single crystal X‐ray analyses. Moreover, the reactivity of 4b towards ethereal HBF₄ was investigated.     

Hybrid of the 1,2,3-triazole nucleus and sesquiterpene skeleton as a potential antitumor agent: Hemisynthesis,molecular structure,Hirshfeld surface analysis,density functional theory,and in vitro cytotoxic and apoptotic effects

A new 1,2,3-triazole sesquiterpenic named (4aR,5aS,7aR,10aR,10bR)-10-benzyl-5,5-dichloro-1,1,4a,7a-tetramethyl-1,2,3,4,4a,5,7a,10,10a,10b decahydrocyclopropa[2′,3′]cyclohepta [1′,2′:3,4]benzo[1,2-d][1,2,3]triazol-7(6H)-one was synthesized by a dipolar cycloaddition 1,3 between benzyl azide and α,β-unsaturated sesquiterpene ketone catalyzed by titanium tetrachloride TiCl₄. It was obtained with a good yield and characterized using single-crystal X-ray diffraction technique, infra red (IR) spectroscopy, High Resolution Mass Spectrometry (HRMS), UV-Visible, and ¹H and ¹³C NMR spectroscopies. The optimization by the density functional theory (DFT) method was carried out to study the formation mechanism of the derivative. The selected compounds 1 – 4 exhibited anticancer activities in vitro against namely fibrosarcoma (HT-1080), lung carcinoma (A-549), and breast (MCF-7 and MDA-MB-231 cell lines with IC₅₀ in the range of 10.02–44.71 μM). In addition to using flow cytometry and the apoptosis assay, cell cycle arrest at the S phase (10 μM) and G2/M arrest in (5 and 10 μM) was performed for compound 4 in fibrosarcoma (HT-1080) cancer cells. Results suggested that compound 4 test with good activity against HT-1080 cells with IC₅₀ value from 10.02 μM and induced the apoptotic effect. Theoretical studies were realized to estimate the molecular proprieties that lead to a high potential of cytotoxic effect, which is in agreement with the experimental results.     

Naphthalene and Anthracene Complexes Sandwiched by Two {(Cp*)FeI} Fragments: Strong Electronic Coupling between the FeI Centers

The reactions of the half‐sandwich iron(II) complex [FeCl(Cp*)(tmeda)] ( 1 ; Cp*=η⁵‐C₅Me₅, TMEDA=N,N,N′,N′‐tetramethylethylenediamine) with potassium naphthalenide or potassium anthracenide gave the diamagnetic complexes [(Cp*)Fe(μ‐polyarene)Fe(Cp*)] (polyarene=naphthalene ( 2 ), anthracene ( 3a )), which have two {(Cp*)Fe} units bound to opposite faces of the polyarene. One of two {(Cp*)Fe} units in 3a is located over the central ring of anthracene while the other is positioned over an outer ring. The {(Cp*)Fe} unit bound to the central ring of 3a migrates to the outer ring upon heating in the solid state to give the isomer 3b . The electrochemical potential separations between successive one‐electron redox events for complexes 2 and 3b are large. The mixed valence complexes [ [2]+ ]⁺ and [ [3b]+ ]⁺ were synthesized by chemical oxidation. The mixed‐valence complex [ [3b]+ ]⁺ is charge delocalized on the Mössbauer timescale at 78 K, and its absorption spectrum shows an intervalence charge‐transfer band. Complex [ [2]+ ]⁺ exhibits two absorption bands in the near‐IR region and a slightly broadened doublet in the Mössbauer spectrum. DFT calculations were carried out to examine the electronic structures of these dinuclear iron(I) complexes to elucidate the factors responsible for their diamagnetism and to determine the degree of charge delocalization in the mixed‐valence complexes.     

Cytotoxic dimeric half-sandwich Ru(II), Os(II) and Ir(III) complexes containing the 4,4′-biphenyl-based bridging ligands

A series of dinuclear half-sandwich Ru(II), Os(II) and Ir(III) complexes [Ru₂(μ-Lⁿ)(η⁶-pcym)₂Cl₂](PF₆)₂ ( 1 , 4 ), [Os₂(μ-Lⁿ)(η⁶-pcym)₂Cl₂](PF₆)₂ ( 2 , 5 ) and [Ir₂(μ-Lⁿ)(η⁵-Cp*)₂Cl₂](PF₆)₂ ( 3 , 6 ), based on 4,4′-biphenyl-based bridging Schiff base ligands N,N′-(biphenyl-4,4′-diyldimethylidyne)bis-2-(pyridin-2-yl)methanamine (L¹; for 1 – 3 ) and N,N′-(biphenyl-4,4′-diyldimethylidyne)bis-2-(pyridin-2-yl)ethanamine (L²; for 4 – 6 ) is reported; pcym = 1-methyl-4-(propan-2-yl)benzene, Cp* = pentamethylcyclopentadienyl. The complexes were characterized by relevant analytical techniques (i.e. elemental analysis, FT-IR, NMR, ESI-MS), and their in vitro cytotoxicity was assessed at six cancerous and two non-cancerous (healthy) human cell lines. Overall, complexes 4 – 6 , containing the L² bridging ligand, revealed higher cytotoxicity as compared with 1 – 3 and, thus, they were studied in greater detail. The best-performing complex 6 exceeded at least twice the in vitro cytotoxicity of cisplatin and showed high selectivity towards the cancer cells over the normal ones, including the primary culture of human hepatocytes. In contrast to cisplatin, complexes 4 – 6 did not induce the cell cycle modification of the treated A2780 human ovarian carcinoma cells (studied by flow cytometry and Western blot analysis). High levels of superoxide anion were induced by complexes 4 – 6 at the A2780 cells. The levels of activated forms of Caspase-3 and Caspase-8 at the A2780 cells treated by Ru(II) complex 4 were comparable with cisplatin, while complexes 5 and 6 had only a minor effect on activation of these caspases.     

Mono- und Di-t-butylcyclopentadienyl-Carbonyl-Komplexe des Eisens und Molybdäns. Die Kristallstruktur von [Cp″Mo(Co)2]2 (Cp″ = n5-C5H3t-Bu2-1,3)

Mono- and Di-t-Butylcyclopentadienyl Carbonyl Complexes of Iron and Molybdenum — Crystal Structure of [Cp″Mo(CO)₂]₂ (Cp″ = n⁵-C₅H₃-t-Bu₂-1,3) Cothermolysis of M(CO)_m (M = Fe, m = 5; M = Mo, m = 6) with t-Bu-substituted cyclopentadienyls constitutes a simple synthesis of complexes of the type [Cp*M(CO)_n]₂ (CP* = n⁵-C₅H₃ (t-Bu), R, R = H, t-Bu; M = Fe, Mo; n = 2, 3). Each synthesis has an optimal temperature. The yield of Fe complexes decreases at temperatures above 130°C because of decomposition of the product. Optimal yields of [Cp*Mo(CO)₃]₂ are obtained at 130–140°C, whereas at 160°C complexes of the type [Cp*Mo(CO)₂]₂ with formal Mo? Mo triple bonds are obtained. The structure of the complexes is discussed on the basis of ¹H-, ¹³C-NMR, IR, and mass spectrometry. The structure of [Cp″Mo(CO)₂]₂ (Cp″ = n⁵-C₅H₃t-Bu₂-1,3) was determined by X-ray crystallography at ?95°C. It crystallises in the space group Pbca, with cell constants a = 1808.6(6), b = 1308.5(4), c = 2507.9(9) pm, Z = 8, R = 0.031 for 3794 reflections. The Mo? Mo bond length of 253.3 pm is very long for a formal triple bond. The Cp″? Mo? Mo? Cp″ axis is non-linear.